FASOL

With Agri Planting – I just made it onto their weekly engagement list by being one of their top engagers! 🎉

People don't buy products. They buy solutions to their problems.

On this Independence Day, we honor the spirit of freedom, unity, and progress that defines our great nation.

At Sami-Sabinsa, we remain committed to contributing towards a healthier, stronger India through science, innovation, and wellness. Happy Independence Day!

Papaya look sweet 😋😋

Mr. Shaheen Majeed, Global CEO and Managing Director, Sabinsa, is quoted in 2 articles published in the July 2025 issue of Nutraceuticals World.

While in one of the articles titled ‘Blood Sugar Becomes Top Wellness Market,’ he emphasized on the expansion of the blood sugar support market beyond diabetes management into mainstream wellness; in the other titled ‘Defending Against Adulteration in the Herbal Products Industry,’ he discusses the serious threats that adulteration in botanical supply chains poses to the industry today.

𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐭𝐨 𝐫𝐞𝐚𝐝 𝐛𝐨𝐭𝐡 𝐭𝐡𝐞 𝐚𝐫𝐭𝐢𝐜𝐥𝐞𝐬:

𝐁𝐥𝐨𝐨𝐝 𝐒𝐮𝐠𝐚𝐫 𝐁𝐞𝐜𝐨𝐦𝐞𝐬 𝐓𝐨𝐩 𝐖𝐞𝐥𝐥𝐧𝐞𝐬𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 – https://shorturl.at/gHgcx
𝐃𝐞𝐟𝐞𝐧𝐝𝐢𝐧𝐠 𝐀𝐠𝐚𝐢𝐧𝐬𝐭 𝐀𝐝𝐮𝐥𝐭𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐇𝐞𝐫𝐛𝐚𝐥 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 - https://shorturl.at/ZTqjI

We’re excited to announce that Sami-Sabinsa will be showcasing our innovative, science-backed ingredients at Fi India 2025!

📅 3rd – 5th September 2025
📍 Stall No.: 11.E10, Hall 11 | Expo Centre & Mart, Greater Noida

Join us to explore our innovative, science-backed ingredients for functional foods, nutraceuticals, and wellness solutions. See you there!

𝐒𝐚𝐦𝐢-𝐒𝐚𝐛𝐢𝐧𝐬𝐚 𝐭𝐨 𝐒𝐡𝐨𝐰𝐜𝐚𝐬𝐞 𝐚𝐭 𝐭𝐡𝐞 𝐕𝐢𝐭𝐚𝐟𝐨𝐨𝐝𝐬 𝐄𝐮𝐫𝐨𝐩𝐞 𝟐𝟎𝟐𝟒 𝐄𝐱𝐩𝐨

Sami-Sabinsa is showcasing its innovations at the 𝐕𝐢𝐭𝐚𝐟𝐨𝐨𝐝𝐬 𝐄𝐮𝐫𝐨𝐩𝐞 𝟐𝟎𝟐𝟒 𝐄𝐱𝐩𝐨. As the official curcumin sponsor of the event, Sami-Sabinsa will highlight its revolutionary product, 𝐂𝟑 𝐑𝐞𝐝𝐮𝐜𝐭® - the only EFSA-approved curcuminoid product in the European market.

𝐃𝐚𝐭𝐞: 14 – 16 May, 2024

𝐕𝐞𝐧𝐮𝐞: Palexpo SA International Exhibition Center in Geneva, Switzerland

𝐒𝐭𝐚𝐧𝐝: A90

Among the portfolio of science-backed ingredients, Sabinsa will showcase:

𝐂𝟑 𝐑𝐞𝐝𝐮𝐜𝐭®: A pioneering formulation offering optimized Curcuminoids with enhanced bioavailability and efficacy.

𝐂𝐢𝐫𝐩𝐮𝐬𝐢𝐧𝐬®: Derived from 𝘊𝘺𝘱𝘦𝘳𝘶𝘴 𝘳𝘰𝘵𝘶𝘯𝘥𝘶𝘴, this innovative product is clinically shown to aid in weight management, including in obese patients.

𝐒𝐚𝐛𝐞𝐫𝐫𝐲®: Extracted from Amla and standardized to 10% beta-glucogallin, Saberry® is clinically studied for its effectiveness in supporting healthy lipid and glucose levels.

𝐍𝐢𝐠𝐞𝐥𝐥𝐢𝐧®: (general health and wellness), extract from the seeds of Nigella sativa (Black Cumin Seed), standardized for 5% and 20% Thymoquinone.



𝐒𝐡𝐚𝐠𝐚𝐧𝐝𝐡𝐚™: Featuring correctly standardized Ashwagandha using USP methodology; recent studies show its potential in reducing stress and anxiety.

𝐒𝐡𝐚𝐡𝐞𝐞𝐧 𝐌𝐚𝐣𝐞𝐞𝐝, 𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐄𝐎 𝐚𝐧𝐝 𝐌𝐚𝐧𝐚𝐠𝐢𝐧𝐠 𝐃𝐢𝐫𝐞𝐜𝐭𝐨𝐫, 𝐒𝐚𝐦𝐢-𝐒𝐚𝐛𝐢𝐧𝐬𝐚 𝐆𝐫𝐨𝐮𝐩, will be at our stand to discuss our ingredients and expertise in supporting your brand.

Our European team, led by 𝐃𝐫. 𝐔𝐦𝐚𝐫 𝐉𝐚𝐧, 𝐏𝐫𝐞𝐬𝐢𝐝𝐞𝐧𝐭 𝐨𝐟 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬, will be present to discuss and demonstrate how Sami-Sabinsa's market-oriented approach in Europe continues to provide high-quality products, exceptional service, and technical sales support to nurture and grow the European client base.

For more information about Sabinsa’s innovative products and their benefits, please visit www.sabinsa.eu.

𝐒𝐚𝐛𝐢𝐧𝐬𝐚 𝐉𝐚𝐩𝐚𝐧 𝐏𝐚𝐲𝐬 𝐓𝐫𝐢𝐛𝐮𝐭𝐞 𝐭𝐨 𝐃𝐫. 𝐌𝐮𝐡𝐚𝐦𝐦𝐞𝐝 𝐌𝐚𝐣𝐞𝐞𝐝

Our team in Japan came together at Ikebukuro in Tokyo to organize “Memorial Day” for its Founder and Nutra industry luminary, Dr. Muhammed Majeed. Along with our Japanese customers and former associates of Sabinsa, our team paid floral tributes to the visionary and recalled their long associations with Dr. Majeed and the company.

Dr. Majeed’s vision to emulate his success of standardized plant extracts globally made Sabinsa set foot in Japan in early 2000, when no other company explored this territory with the concept of Ayurveda. With over 75 ingredients focused on health support and beauty, Sabinsa is now a preferred innovation and formulation partner for many reputed brands in this tough-to-crack Japanese market. Thanks to Dr. Majeed's remarkable business foresight.

Dr. Majeed’s commitment to societal welfare made him establish the Dr. Majeed Foundation, which focused on healthcare, education, and other socioeconomic development activities.

Remembering the legend and his legacy, a video documentary on Dr. Majeed was played to the guests at the event. (https://sami-sabinsagroup.com/founder)

Characterized by a blend of leadership qualities, innovative thinking, and empathy, Dr. Majeed passed away last month at the age of 75 in Chennai, India.

Dr. Majeed is succeeded as Chairperson of the Sami-Sabinsa Group by his daughter, Dr. Anju Majeed, Director and senior scientist. His only son, Shaheen Majeed, returns as the Global Managing Director & CEO. He is survived by his daughters Anju and Sami, his son Shaheen, and his grandchildren Rizwan, Johara, Nasneen, Ramses, Sunayna, Rajah, and Maximo.



-Sabinsa